# Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/obesity-and-overweight-developing-drugs-and-biological-products-for-weight-reduction/d3075b32-e4bf-4368-aa3d-a04e7457ded0

> FDA guidance document: Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction. Issue date: January 07, 2025. Get complete insights and analysis.

---

## Details

- Title: Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2025-01-07
- Comment Close Date: 2025-04-08
- Last Changed: 2025-06-04
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2007-D-0435">FDA-2007-D-0435</a>

## Related Documents

- [Erosive Esophagitis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment/985e94e3-4616-49e9-822e-0854256bb10e)
- [Developing Drugs for Optical Imaging](https://www.globalkeysolutions.net/guidances/guidance-document/developing-drugs-for-optical-imaging/231d0a9f-1739-4bcd-8393-28d3bcb52cfa)
- [Mpox: Development of Drugs and Biological Products; Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/mpox-development-of-drugs-and-biological-products-guidance-for-industry/ef1c9a82-c229-49ef-a357-d9947fb4dcdb)